Odontogenic Infections News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ICPA Health launches antibiotic to treat odontogenic infections
ICPA Health launches antibiotic to treat odontogenic infections
02 March 2021 | News
ICPAMOX – CV 625 is recommended for use along with dental treatments like root canal, tooth extractions and various oral surgeries to reduce post-operative infection.
Mumbai based ICPA Health Products Ltd (ICPA), a leading pharmaceutical company and pioneers in the oral-health segment, has launched ICPAMOX – CV 625 meant to treat odontogenic infections.
The product is an antibiotic with a broad-spectrum activity against the commonly occurring bacterial pathogens in the oral cavity and other parts of the body. An antibiotic indicated in multiple conditions, ICPAMOX – CV 625 is recommended for use along with dental treatments like root canal, tooth extractions and various oral surgeries to reduce post-operative infection. ....

Abha Damani , Health Products Ltd , Products Ltd , Icpamox Cv 625 , Clavulanic Acid , Odontogenic Infections , அபா தமணி , ஆரோக்கியம் ப்ராடக்ட்ஸ் லிமிடெட் , ப்ராடக்ட்ஸ் லிமிடெட் ,